Table 1.
Operational definitions of TB treatment outcomes: end of intensive phase and end of treatment [34].
Fig 1.
PRISMA flow diagram through different phases of the systematic review [39].
Table 2.
Characteristics of the studies excluded from the systematic review*.
Table 3.
Effect of glycemic control (stringent or less stringent) on unfavourable TB treatment outcomes, summarized as unadjusted relative risk (RR)* [40–47].
Table 4.
Effect of glucose lowering treatment on unfavourable TB treatment outcomes, summarized as unadjusted relative risk (RR)* [47,48].
Table 5.
Summary of risk of bias in included studies assessed using New Castle Ottawa quality assessment scale for cohort studies [37].